(APAM) Aperam - Overview
Exchange: AS •
Country: Luxembourg •
Currency: EUR •
Type: Common Stock •
ISIN: LU0569974404
Stock:
Total Rating 51
Risk 73
Buy Signal -0.05
| Risk 5d forecast | |
|---|---|
| Volatility | 33.1% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.31 |
| Alpha | 41.57 |
| Character TTM | |
|---|---|
| Beta | 0.848 |
| Beta Downside | 1.861 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.69% |
| CAGR/Max DD | 0.68 |
EPS (Earnings per Share)
Revenue
Description: APAM Aperam
Aperam S.A., together with its subsidiaries, produces and sells stainless steel and alloy products worldwide. It operates through four segments: Stainless & Electrical Steel; Services & Solutions; Alloys & Specialties; and Recycling & Renewables. The company offers a range of stainless steel and electrical steel products, including grain oriented and non-grain oriented. It is also involved in the management of direct sales of stainless steel products from production facilities; distribution of its products; and the provision of transformation services that include value added and customized steel solutions. In addition, the company designs, produces, and transforms various specialty alloys and other specific stainless steels in forms, such as bars, semis, cold-rolled strips, wire and wire rods, and plates in a range on grades. Further, it engages in the trading, processing, and recycling of stainless steel, superalloys, titanium, and special metal scrap, as well as raw materials; provision of Recyco, an electric arc furnace recycling facility that retrieves and recycle dust and sludge to stainless steel raw materials and reduce waste; and production of wood and charcoal from cultivated eucalyptus forests. The company serves aerospace, automotive, construction, medical, and oil and gas industries. It distributes its products through a network of steel service centers, transformation facilities, and sales offices. The company was incorporated in 2010 and is headquartered in Luxembourg, Luxembourg.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 9.00m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 3.21 > 1.0 |
| NWC/Revenue: 21.76% < 20% (prev 19.33%; Δ 2.43% < -1%) |
| CFO/TA 0.08 > 3% & CFO 422.0m > Net Income 9.00m |
| Net Debt (978.0m) to EBITDA (275.0m): 3.56 < 3 |
| Current Ratio: 3.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (73.1m) vs 12m ago 1.11% < -2% |
| Gross Margin: 77.66% > 18% (prev 0.07%; Δ 7760 % > 0.5%) |
| Asset Turnover: 110.4% > 50% (prev 107.1%; Δ 3.29% > 0%) |
| Interest Coverage Ratio: 0.18 > 6 (EBITDA TTM 275.0m / Interest Expense TTM 90.0m) |
Altman Z''
| A: 0.26 (Total Current Assets 1.94b - Total Current Liabilities 615.0m) / Total Assets 5.17b |
| B: error (Retained Earnings missing) |
| C: 0.00 (EBIT TTM 16.0m / Avg Total Assets 5.51b) |
| D: 1.63 (Book Value of Equity 3.19b / Total Liabilities 1.97b) |
Beneish M
| DSRI: none (Receivables none/342.0m, Revenue 6.08b/6.25b) |
| GMI: 0.08 (GM 77.66% / 6.52%) |
| AQI: 1.25 (AQ_t 0.20 / AQ_t-1 0.16) |
| SGI: 0.97 (Revenue 6.08b / 6.25b) |
| TATA: -0.08 (NI 9.00m - CFO 422.0m) / TA 5.17b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of APAM shares?
As of February 25, 2026, the stock is trading at EUR 43.10 with a total of 161,654 shares traded.
Over the past week, the price has changed by +6.97%, over one month by +22.75%, over three months by +38.86% and over the past year by +59.68%.
Over the past week, the price has changed by +6.97%, over one month by +22.75%, over three months by +38.86% and over the past year by +59.68%.
Is APAM a buy, sell or hold?
Aperam has no consensus analysts rating.
What are the forecasts/targets for the APAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.3 | -27.5% |
| Analysts Target Price | - | - |
APAM Fundamental Data Overview February 21, 2026
Market Cap USD = 2.67b (2.26b EUR * 1.1784 EUR.USD)
P/E Forward = 11.2233
P/S = 0.5186
P/B = 0.9453
P/EG = 0.85
Revenue TTM = 6.08b EUR
EBIT TTM = 16.0m EUR
EBITDA TTM = 275.0m EUR
Long Term Debt = 1.07b EUR (estimated: total debt 1.30b - short term 233.0m)
Short Term Debt = 233.0m EUR (from shortTermDebt, last quarter)
Debt = 1.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 978.0m EUR (from netDebt column, last quarter)
Enterprise Value = 3.24b EUR (2.26b + Debt 1.30b - CCE 325.0m)
Interest Coverage Ratio = 0.18 (Ebit TTM 16.0m / Interest Expense TTM 90.0m)
EV/FCF = 11.78x (Enterprise Value 3.24b / FCF TTM 275.0m)
FCF Yield = 8.49% (FCF TTM 275.0m / Enterprise Value 3.24b)
FCF Margin = 4.52% (FCF TTM 275.0m / Revenue TTM 6.08b)
Net Margin = 0.15% (Net Income TTM 9.00m / Revenue TTM 6.08b)
Gross Margin = 77.66% ((Revenue TTM 6.08b - Cost of Revenue TTM 1.36b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.63 (Enterprise Value 3.24b / Total Assets 5.17b)
Interest Expense / Debt = 1.84% (Interest Expense 24.0m / Debt 1.30b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 12.0m (EBIT 16.0m * (1 - 25.00%))
Current Ratio = 3.15 (Total Current Assets 1.94b / Total Current Liabilities 615.0m)
Debt / Equity = 0.41 (Debt 1.30b / totalStockholderEquity, last quarter 3.19b)
Debt / EBITDA = 3.56 (Net Debt 978.0m / EBITDA 275.0m)
Debt / FCF = 3.56 (Net Debt 978.0m / FCF TTM 275.0m)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.16% (Net Income 9.00m / Total Assets 5.17b)
RoE = 0.28% (Net Income TTM 9.00m / Total Stockholder Equity 3.22b)
RoCE = 0.37% (EBIT 16.0m / Capital Employed (Equity 3.22b + L.T.Debt 1.07b))
RoIC = 0.37% (NOPAT 12.0m / Invested Capital 3.22b)
WACC = 6.24% (E(2.26b)/V(3.57b) * Re(9.04%) + D(1.30b)/V(3.57b) * Rd(1.84%) * (1-Tc(0.25)))
Discount Rate = 9.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.22%
[DCF] Terminal Value 84.11% ; FCFF base≈214.2m ; Y1≈199.3m ; Y5≈182.6m
[DCF] Fair Price = 54.81 (EV 4.94b - Net Debt 978.0m = Equity 3.96b / Shares 72.3m; r=6.24% [WACC]; 5y FCF grow -8.83% → 2.90% )
EPS Correlation: -50.60 | EPS CAGR: -40.67% | SUE: -0.50 | # QB: 0
Revenue Correlation: -77.10 | Revenue CAGR: -12.75% | SUE: -0.33 | # QB: 0
EPS next Year (2026-12-31): EPS=2.42 | Chg7d=-0.452 | Chg30d=-0.568 | Revisions Net=-2 | Growth EPS=+1627.7% | Growth Revenue=+11.8%
P/E Forward = 11.2233
P/S = 0.5186
P/B = 0.9453
P/EG = 0.85
Revenue TTM = 6.08b EUR
EBIT TTM = 16.0m EUR
EBITDA TTM = 275.0m EUR
Long Term Debt = 1.07b EUR (estimated: total debt 1.30b - short term 233.0m)
Short Term Debt = 233.0m EUR (from shortTermDebt, last quarter)
Debt = 1.30b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 978.0m EUR (from netDebt column, last quarter)
Enterprise Value = 3.24b EUR (2.26b + Debt 1.30b - CCE 325.0m)
Interest Coverage Ratio = 0.18 (Ebit TTM 16.0m / Interest Expense TTM 90.0m)
EV/FCF = 11.78x (Enterprise Value 3.24b / FCF TTM 275.0m)
FCF Yield = 8.49% (FCF TTM 275.0m / Enterprise Value 3.24b)
FCF Margin = 4.52% (FCF TTM 275.0m / Revenue TTM 6.08b)
Net Margin = 0.15% (Net Income TTM 9.00m / Revenue TTM 6.08b)
Gross Margin = 77.66% ((Revenue TTM 6.08b - Cost of Revenue TTM 1.36b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.63 (Enterprise Value 3.24b / Total Assets 5.17b)
Interest Expense / Debt = 1.84% (Interest Expense 24.0m / Debt 1.30b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 12.0m (EBIT 16.0m * (1 - 25.00%))
Current Ratio = 3.15 (Total Current Assets 1.94b / Total Current Liabilities 615.0m)
Debt / Equity = 0.41 (Debt 1.30b / totalStockholderEquity, last quarter 3.19b)
Debt / EBITDA = 3.56 (Net Debt 978.0m / EBITDA 275.0m)
Debt / FCF = 3.56 (Net Debt 978.0m / FCF TTM 275.0m)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.16% (Net Income 9.00m / Total Assets 5.17b)
RoE = 0.28% (Net Income TTM 9.00m / Total Stockholder Equity 3.22b)
RoCE = 0.37% (EBIT 16.0m / Capital Employed (Equity 3.22b + L.T.Debt 1.07b))
RoIC = 0.37% (NOPAT 12.0m / Invested Capital 3.22b)
WACC = 6.24% (E(2.26b)/V(3.57b) * Re(9.04%) + D(1.30b)/V(3.57b) * Rd(1.84%) * (1-Tc(0.25)))
Discount Rate = 9.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.22%
[DCF] Terminal Value 84.11% ; FCFF base≈214.2m ; Y1≈199.3m ; Y5≈182.6m
[DCF] Fair Price = 54.81 (EV 4.94b - Net Debt 978.0m = Equity 3.96b / Shares 72.3m; r=6.24% [WACC]; 5y FCF grow -8.83% → 2.90% )
EPS Correlation: -50.60 | EPS CAGR: -40.67% | SUE: -0.50 | # QB: 0
Revenue Correlation: -77.10 | Revenue CAGR: -12.75% | SUE: -0.33 | # QB: 0
EPS next Year (2026-12-31): EPS=2.42 | Chg7d=-0.452 | Chg30d=-0.568 | Revisions Net=-2 | Growth EPS=+1627.7% | Growth Revenue=+11.8%